TRIP6 Regulates p27^KIP1 To Promote Tumorigenesis

REFERENCES

• Lin VT, Lin FT. 2011. TRIP6: an adaptor protein that regulates cell motility, antiapoptotic signaling and transcriptional activity. Cell. Signal. 23:1691–1697.
   PubMedGoogle Scholar
• Lai YJ, Chen CS, Lin WC, Lin FT. 2005. c-Src-mediated phosphorylation of TRIP6 regulates its function in lysophosphatidic acid-induced cell migration. Mol. Cell. Biol. 25:5859–5868.
   PubMedGoogle Scholar
• Lai YJ, Lin VT, Zheng Y, Benveniste EN, Lin FT. 2010. The adaptor protein TRIP6 antagonizes Fas-induced apoptosis but promotes its effect on cell migration. Mol. Cell. Biol. 30:5582–5596.
   PubMedGoogle Scholar
• Xu J, Lai YJ, Lin WC, Lin FT. 2004. TRIP6 enhances lysophosphatidic acid-induced cell migration by interacting with the lysophosphatidic acid 2 receptor. J. Biol. Chem. 279:10459–10468.
   PubMedGoogle Scholar
• E S, Lai YJ, Tsukahara R, Chen CS, Fujiwara Y, Yue J, Yu JH, Guo H, Kihara A, Tigyi G, Lin FT. 2009. Lysophosphatidic acid 2 receptor-mediated supramolecular complex formation regulates its antiapoptotic effect. J. Biol. Chem. 284:14558–14571.
   PubMedGoogle Scholar
• Kassel O, Schneider S, Heilbock C, Litfin M, Gottlicher M, Herrlich P. 2004. A nuclear isoform of the focal adhesion LIM-domain protein Trip6 integrates activating and repressing signals at AP-1- and NF-kappaB-regulated promoters. Genes Dev. 18:2518–2528.
   PubMed Web of Science ®Google Scholar
• Chu IM, Hengst L, Slingerland JM. 2008. The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy. Nat. Rev. Cancer 8:253–267.
   PubMed Web of Science ®Google Scholar
• Besson A, Gurian-West M, Schmidt A, Hall A, Roberts JM. 2004. p27Kip1 modulates cell migration through the regulation of RhoA activation. Genes Dev. 18:862–876.
   PubMed Web of Science ®Google Scholar
• Wander SA, Zhao D, Slingerland JM. 2011. p27: a barometer of signaling deregulation and potential predictor of response to targeted therapies. Clin. Cancer Res. 17:12–18.
   PubMed Web of Science ®Google Scholar
• Vervoorts J, Luscher B. 2008. Post-translational regulation of the tumor suppressor p27(KIP1). Cell. Mol. Life Sci. 65:3255–3264.
   PubMedGoogle Scholar
• Boehm M, Yoshimoto T, Crook MF, Nallamshetty S, True A, Nabel GJ, Nabel EG. 2002. A growth factor-dependent nuclear kinase phosphorylates p27(Kip1) and regulates cell cycle progression. EMBO J. 21:3390–3401.
   PubMed Web of Science ®Google Scholar
• Montagnoli A, Fiore F, Eytan E, Carrano AC, Draetta GF, Hershko A, Pagano M. 1999. Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation. Genes Dev. 13:1181–1189.
   PubMed Web of Science ®Google Scholar
• Lundgren E, Roos G. 1976. Cell surface changes in HeLa cells as an indication of cell cycle events. Cancer Res. 36:4044–4051.
   PubMedGoogle Scholar
• Debnath J, Muthuswamy SK, Brugge JS. 2003. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 30:256–268.
   PubMed Web of Science ®Google Scholar
• Lin FT, Lai YJ, Makarova N, Tigyi G, Lin WC. 2007. The lysophosphatidic acid 2 receptor mediates down-regulation of Siva-1 to promote cell survival. J. Biol. Chem. 282:37759–37769.
   PubMed Web of Science ®Google Scholar
• Lin FT, Krueger KM, Kendall HE, Daaka Y, Fredericks ZL, Pitcher JA, Lefkowitz RJ. 1997. Clathrin-mediated endocytosis of the beta-adrenergic receptor is regulated by phosphorylation/dephosphorylation of beta-arrestin1. J. Biol. Chem. 272:31051–31057.
   PubMed Web of Science ®Google Scholar
• McAllister SS, Becker-Hapak M, Pintucci G, Pagano M, Dowdy SF. 2003. Novel p27(kip1) C-terminal scatter domain mediates Rac-dependent cell migration independent of cell cycle arrest functions. Mol. Cell. Biol. 23:216–228.
   PubMed Web of Science ®Google Scholar
• Kohn AD, Takeuchi F, Roth RA. 1996. Akt, a pleckstrin homology domain containing kinase, is activated primarily by phosphorylation. J. Biol. Chem. 271:21920–21926.
   PubMed Web of Science ®Google Scholar
• Wang Y, Gilmore TD. 2003. Zyxin and paxillin proteins: focal adhesion plaque LIM domain proteins go nuclear. Biochim. Biophys. Acta 1593:115–120.
   PubMed Web of Science ®Google Scholar
• Feuerstein R, Wang X, Song D, Cooke NE, Liebhaber SA. 1994. The LIM/double zinc-finger motif functions as a protein dimerization domain. Proc. Natl. Acad. Sci. U. S. A. 91:10655–10659.
   PubMed Web of Science ®Google Scholar
• Du K, Tsichlis PN. 2005. Regulation of the Akt kinase by interacting proteins. Oncogene 24:7401–7409.
   PubMedGoogle Scholar
• Scheid MP, Woodgett JR. 2003. Unravelling the activation mechanisms of protein kinase B/Akt. FEBS Lett. 546:108–112.
   PubMed Web of Science ®Google Scholar
• Chun J, Kwon T, Lee E, Suh PG, Choi EJ, Sun Kang S. 2002. The Na(+)/H(+) exchanger regulatory factor 2 mediates phosphorylation of serum- and glucocorticoid-induced protein kinase 1 by 3-phosphoinositide-dependent protein kinase 1. Biochem. Biophys. Res. Commun. 298:207–215.
   PubMed Web of Science ®Google Scholar
• Barre B, Perkins ND. 2010. The Skp2 promoter integrates signaling through the NF-kappaB, p53, and Akt/GSK3beta pathways to regulate autophagy and apoptosis. Mol. Cell 38:524–538.
   PubMed Web of Science ®Google Scholar
• Chan CH, Lee SW, Wang J, Lin HK. 2010. Regulation of Skp2 expression and activity and its role in cancer progression. ScientificWorldJournal 10:1001–1015.
   PubMedGoogle Scholar
• Freije WA, Castro-Vargas FE, Fang Z, Horvath S, Cloughesy T, Liau LM, Mischel PS, Nelson SF. 2004. Gene expression profiling of gliomas strongly predicts survival. Cancer Res. 64:6503–6510.
   PubMed Web of Science ®Google Scholar
• Freeman AK, Morrison DK. 2011. 14-3-3 proteins: diverse functions in cell proliferation and cancer progression. Semin. Cell Dev. Biol. 22:681–687.
   PubMed Web of Science ®Google Scholar